Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Therapeutic potential of the endocannabinoid system in the brain.

Ramos JA, González S, Sagredo O, Gómez-Ruiz M, Fernández-Ruiz J.

Mini Rev Med Chem. 2005 Jul;5(7):609-17. Review.

PMID:
16026307
2.

An overview on the biochemistry of the cannabinoid system.

Gómez-Ruiz M, Hernández M, de Miguel R, Ramos JA.

Mol Neurobiol. 2007 Aug;36(1):3-14. Epub 2007 Jun 30. Review.

PMID:
17952645
3.

The endocannabinoid system and pain.

Guindon J, Hohmann AG.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21. Review.

4.

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.

Lambert DM, Fowler CJ.

J Med Chem. 2005 Aug 11;48(16):5059-87. Review. No abstract available.

PMID:
16078824
5.

The endocannabinoid system: physiology and pharmacology.

Rodríguez de Fonseca F, Del Arco I, Bermudez-Silva FJ, Bilbao A, Cippitelli A, Navarro M.

Alcohol Alcohol. 2005 Jan-Feb;40(1):2-14. Epub 2004 Nov 18. Review.

PMID:
15550444
6.

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.

Cabranes A, Venderova K, de Lago E, Fezza F, Sánchez A, Mestre L, Valenti M, García-Merino A, Ramos JA, Di Marzo V, Fernández-Ruiz J.

Neurobiol Dis. 2005 Nov;20(2):207-17.

PMID:
16242629
7.

Endocannabinoid System: A Multi-Facet Therapeutic Target.

Kaur R, Ambwani SR, Singh S.

Curr Clin Pharmacol. 2016;11(2):110-7. Review.

PMID:
27086601
8.

Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications.

Snider NT, Walker VJ, Hollenberg PF.

Pharmacol Rev. 2010 Mar;62(1):136-54. doi: 10.1124/pr.109.001081. Epub 2010 Feb 4. Review.

9.

Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.

Giuffrida A, Beltramo M, Piomelli D.

J Pharmacol Exp Ther. 2001 Jul;298(1):7-14. Review.

10.

Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.

De Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S, Stott CG, Di Marzo V.

Br J Pharmacol. 2011 Aug;163(7):1479-94. doi: 10.1111/j.1476-5381.2010.01166.x.

11.

Psychopharmacology of the endocannabinoids: far beyond anandamide.

Pamplona FA, Takahashi RN.

J Psychopharmacol. 2012 Jan;26(1):7-22. doi: 10.1177/0269881111405357. Epub 2011 Jun 7. Review.

PMID:
21652605
12.

Cannabinoid/Endocannabinoid signaling impact on early pregnancy events.

Sun X, Dey SK.

Curr Top Behav Neurosci. 2009;1:255-73. doi: 10.1007/978-3-540-88955-7_10. Review.

PMID:
21104387
13.

Fatty acid amide hydrolase localization in the human central nervous system: an immunohistochemical study.

Romero J, Hillard CJ, Calero M, Rábano A.

Brain Res Mol Brain Res. 2002 Apr 30;100(1-2):85-93.

PMID:
12008024
14.

Cannabinoids biology: the search for new therapeutic targets.

Felder CC, Dickason-Chesterfield AK, Moore SA.

Mol Interv. 2006 Jun;6(3):149-61. Review.

PMID:
16809476
15.

Cannabinoids and the gut: new developments and emerging concepts.

Izzo AA, Sharkey KA.

Pharmacol Ther. 2010 Apr;126(1):21-38. doi: 10.1016/j.pharmthera.2009.12.005. Epub 2010 Feb 1. Review.

PMID:
20117132
16.

Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.

Pertwee RG.

Addict Biol. 2008 Jun;13(2):147-59. doi: 10.1111/j.1369-1600.2008.00108.x. Review.

PMID:
18482430
17.

Cannabinoids and pain.

Rice AS.

Curr Opin Investig Drugs. 2001 Mar;2(3):399-414. Review.

PMID:
11575713
18.
19.

Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.

Gertsch J.

Planta Med. 2008 May;74(6):638-50. doi: 10.1055/s-2008-1034302. Epub 2008 Feb 14. Review.

PMID:
18275004
20.

Endogenous cannabinoids: structure and metabolism.

Bisogno T.

J Neuroendocrinol. 2008 May;20 Suppl 1:1-9. doi: 10.1111/j.1365-2826.2008.01676.x. Review.

PMID:
18426492

Supplemental Content

Support Center